Senate panel passes Clarity Act, clearing CFTC path for CME Bitcoin derivatives

2 min

CME focuses on Bitcoin–Nasdaq correlation and the Clarity Act as a trading catalyst

CME Group published analysis indicating persistent correlation between Bitcoin and the Nasdaq. After moving above $80,000, price drifted toward ~$77,000 in line with tech-equity weakness.
Digital Asset Market Clarity Act advanced: Senate Banking Committee passed it 15–9 on May 14, 2026. The bill heads to the full Senate; the House passed it in 2025.
Core change: Bitcoin and Ethereum classified as digital commodities under CFTC oversight when decentralization and absence of an active issuer are met. SEC registration and disclosure would not apply for those assets.
New registration regimes for digital commodity exchanges, brokers, and dealers align the spot market with Commodity Exchange Act standards.
CME is calibrating derivatives product plans to the bill’s outcome. Prediction markets assign ~56% odds to Senate passage in 2026; these odds are used in pricing CME-listed Bitcoin options volatility.
CME noted Senate delays contributed to selling pressure. Coinbase Premium Index stayed negative through 2025, consistent with futures-led price recovery while institutional spot allocation awaited regulatory clarity.
CME announced 24/7 crypto futures and options trading from May 29, pending regulatory review.

Regulatory resolution would set CFTC oversight for Bitcoin and Ethereum, affecting listings, compliance, and institutional participation.
Correlation with the Nasdaq increases exposure to tech-equity risk factors in crypto portfolios.
Expect volatility around Senate milestones and CME’s 24/7 derivatives rollout, with ~56% passage odds influencing options pricing.